Healix

Successful, Cost-Saving Outpatient Parenteral Antimicrobial Therapy (OPAT) Following Hospital Discharge: Early Pilot Study of an Indigent Healthcare Program between a Physician Office Infusion Center (POIC) and Two Tucson Hospitals

Authors:
Richard M. Mandel, MD, – Southern Arizona Infectious Disease Specialists, PLC, Tucson, AZ
Clifford P. Martin, MD – Southern Arizona Infectious Disease Specialists, PLC, Tucson, AZ
Thuy N. Sixt, PharmD, -Healix Infusion Therapy, Inc. Sugar Land, TX
Lucinda J. Van Anglen, PharmD, – Healix Infusion Therapy, Inc. Sugar Land, TX
E. Jolene Patterson, PharmD – Healix Infusion Therapy, Inc. Tucson, AZ

View Poster

View All

Phase II and Phase III Studies

Healix regularly and actively supports Phase II and Phase III clinical trials in each of our specialty areas, including active studies in Multiple Sclerosis and Intestinal Bowel Disease.

For information on partnering with Healix on a study, please contact us.

FacebookTwitterLinkedInarrow1arcsearchiconowdtnotfound